Skip to the main content.

A Comparison of Multimodal Chromatography Resin | Case Study

Mixed Mode Chromatography & KBI's mAB Purification Platform

KBI Biopharma, Inc. Announces Collaboration with Infinimmune Inc. to Support Antibody Manufacturing

KBI Biopharma, Inc. Announces Collaboration with Infinimmune Inc. to Support Antibody Manufacturing

Durham, North Carolina and Alameda, California (September 08, 2025) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract...

Read More
KBI Biopharma Awarded as Global Leader in Biologics Manufacturing

KBI Biopharma Awarded as Global Leader in Biologics Manufacturing

Durham, North Carolina (April 3, 2025) – KBI Biopharma, a JSR Life Sciences Company and leading global contract development and manufacturing...

Read More
KBI Biopharma to Lead Development and Manufacturing of Alanis Therapeutics’ Antagonistic Antibody Candidate

KBI Biopharma to Lead Development and Manufacturing of Alanis Therapeutics’ Antagonistic Antibody Candidate

KBI Biopharma Selected as CDMO of Choice to Fast-Track Development of Pre-Clinical Antibody for Blood Cancers Using SUREmAbTM Technology Durham,...

Read More